Participant 0 11 0 11 O
who 12 15 12 15 O
already 16 23 16 23 O
has 24 27 24 27 O
stored 28 34 28 34 O
cryopreserved 35 48 35 48 O
ovarian 49 56 49 56 O
tissue 57 63 57 63 O
in 64 66 64 66 O
a 67 68 67 68 O
frozen 69 75 69 75 O
state 76 81 76 81 O
prior 82 87 82 87 O
to 88 90 88 90 O
undergoing 91 101 91 101 O
cancer 102 108 102 108 B-treatment
treatments 109 119 109 119 I-treatment
( 120 121 120 121 O
surgery 121 128 121 128 B-treatment
, 128 129 128 129 O
chemotherapy 130 142 130 142 B-treatment
or 143 145 143 145 O
radiation 146 155 146 155 B-treatment
) 155 156 155 156 O

Participants 0 12 157 169 O
with 13 17 170 174 O
a 18 19 175 176 O
large 20 25 177 182 B-cancer
cancerous 26 35 183 192 I-cancer
mass 36 40 193 197 I-cancer
in 41 43 198 200 I-cancer
the 44 47 201 204 I-cancer
ovary 48 53 205 210 I-cancer
that 54 58 211 215 O
is 59 61 216 218 O
being 62 67 219 224 O
removed 68 75 225 232 O
; 75 76 232 233 O
cryopreservation 77 93 234 250 O
will 94 98 251 255 O
not 99 102 256 259 O
be 103 105 260 262 O
performed 106 115 263 272 O
on 116 118 273 275 O
portions 119 127 276 284 O
of 128 130 285 287 O
the 131 134 288 291 O
ovary 135 140 292 297 O

Psychological 0 13 298 311 B-chronic_disease
, 13 14 311 312 O
psychiatric 15 26 313 324 B-chronic_disease
or 27 29 325 327 O
other 30 35 328 333 O
conditions 36 46 334 344 O
which 47 52 345 350 O
prevent 53 60 351 358 O
giving 61 67 359 365 O
fully 68 73 366 371 O
informed 74 82 372 380 O
consent 83 90 381 388 O

Undergo 0 7 389 396 O
standard 8 16 397 405 O
of 17 19 406 408 O
care 20 24 409 413 O
surgery 25 32 414 421 B-treatment
, 32 33 421 422 O
chemotherapy 34 46 423 435 B-treatment
, 46 47 435 436 O
drug 48 52 437 441 B-treatment
treatment 53 62 442 451 I-treatment
, 62 63 451 452 O
and/or 64 70 453 459 O
radiation 71 80 460 469 O
for 81 84 470 473 O
the 85 88 474 477 O
treatment 89 98 478 487 O
or 99 101 488 490 O
prevention 102 112 491 501 O
of 113 115 502 504 O
a 116 117 505 506 O
medical 118 125 507 514 O
condition 126 135 515 524 O
or 136 138 525 527 O
malignancy 139 149 528 538 B-cancer
expected 150 158 539 547 O
to 159 161 548 550 O
result 162 168 551 557 O
in 169 171 558 560 O
permanent 172 181 561 570 O
and 182 185 571 574 O
complete 186 194 575 583 O
loss 195 199 584 588 O
of 200 202 589 591 O
subsequent 203 213 592 602 O
ovarian 214 221 603 610 O
function 222 230 611 619 O

Underlying 0 10 620 630 O
medical 11 18 631 638 O
condition 19 28 639 648 O
which 29 34 649 654 O
significantly 35 48 655 668 O
increases 49 58 669 678 O
risk 59 63 679 683 O
of 64 66 684 686 O
complications 67 80 687 700 O
from 81 85 701 705 O
anesthesia 86 96 706 716 B-treatment
and 97 100 717 720 O
surgery 101 108 721 728 B-treatment

have 0 4 729 733 O
a 5 6 734 735 O
medical 7 14 736 743 O
condition 15 24 744 753 O
or 25 27 754 756 O
malignancy 28 38 757 767 B-cancer
that 39 43 768 772 O
requires 44 52 773 781 O
removal 53 60 782 789 O
of 61 63 790 792 O
all 64 67 793 796 O
or 68 70 797 799 O
part 71 75 800 804 O
of 76 78 805 807 O
one 79 82 808 811 O
or 83 85 812 814 O
both 86 90 815 819 O
ovaries 91 98 820 827 O

